We are live on ! Find out more
BME icon

BlackRock Health Sciences Trust

62 hedge funds and large institutions have $98.2M invested in BlackRock Health Sciences Trust in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 13

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

7% more funds holding

Funds holding: 5862 (+4)

1.38% more ownership

Funds ownership: 17.04%18.43% (+1.4%)

1% more capital invested

Capital invested by funds: $97.4M → $98.2M (+$789K)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
62
Holders Change
+4
Holders Change %
+6.9%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
23
Reduced
13
Closed
8
Calls
Puts
Net Calls
Net Calls Change

BME Hedge Fund Activity: Q2 2022 in Review

62 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust (BME) for Q2 2022, worth a combined $98.2M — up 0.81% from $97.4M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BME positions and 8 closed out — a net gain of 4 holders — while 23 added to existing stakes and 13 trimmed.

The largest buyer was Ameriprise, adding an estimated $4.18M. The largest seller was Nova R Wealth, cutting an estimated $1.07M.

  • 62 institutional investors held BlackRock Health Sciences Trust (BME) as of Q2 2022, up from 58 in Q1 2022.
  • Funds reported $98.2M of BlackRock Health Sciences Trust stock for Q2 2022, up 0.81% quarter-over-quarter.
  • 12 funds opened new BlackRock Health Sciences Trust positions in Q2 2022 and 8 closed out, a net change of +4 holders.
  • The largest BlackRock Health Sciences Trust buyer in Q2 2022 was Ameriprise, an estimated $4.18M added.
  • The largest BlackRock Health Sciences Trust seller in Q2 2022 was Nova R Wealth, an estimated $1.07M sold.

Based on aggregated 13F filings for Q2 2022.